Here's your summary from J&J CFO on Q2 Earnings, Acquisitions and Product Portfolio (https://www.youtube.com/watch?v=eT4-E0l-aCE) on the Bloomberg Television channel:

### TLDR:

Johnson & Johnson CFO discusses Q2 earnings, acquisitions, and product portfolio, highlighting strong performance, impact of recent acquisitions, and future growth plans.

### Key Points:

1. Johnson & Johnson beat on adjusted EPS and second quarter profit, but lowered full year forecast due to recent acquisitions.

2. The company made important acquisitions like Shockwave and to buy specifics for atopic dermatitis, impacting financials in the short term.

3. Despite challenges like losing patent exclusivity for STELARA, J&J remains confident in its diverse portfolio and plans for future growth.

#finance #tradfi #markets #stocks #stockmarket #bloomberg #macro nostr:npub1849ntz6s6gxrunv9tunnlurvfx7xk0mwvtzz4m2y7fu8gt7408dqsl0qen nostr:npub1tlvvdgm4csch9x3m0r3qsrll7zsaccl49c4gdz5qz9g3jz33l92ss4gp7z